Prognostic value of tumor size, metastases, extension into bone, and increased tumor marker in children with malignant sacrococcygeal germ cell tumors: A prospective evaluation of 71 patients treated in the German Cooperative Protocols Maligne Keimzelltumoren (MAKEI) 83/86 and MAKEI 89

Journal of Clinical Oncology

Volumn 21, Issue 5, 2003, Pages 781-786

  Calaminus, Gabriele ^a   Schneider, D T ^a   Bokkerink J P M ^a   Gadner, H ^a   Harms, D ^a   Willers, R ^a   Gobel U ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; TUMOR MARKER; ANTINEOPLASTIC AGENT;

ARTICLE; BONE METASTASIS; CANCER RELAPSE; CANCER STAGING; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EMBRYONAL CARCINOMA; GERM CELL TUMOR; HUMAN; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; MATRICARIA; MEDICAL SOCIETY; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SACROCOCCYX TUMOR; TERATOMA; TUMOR VOLUME; YOLK SAC TUMOR; BACK; BLOOD; BONE TUMOR; CANCER INVASION; FEMALE; INFANT; MALE; MULTIMODALITY CANCER THERAPY; NEOPLASM; PATHOLOGY; PRESCHOOL CHILD; RISK FACTOR; TESTIS TUMOR; TREATMENT OUTCOME;

ALPHA-FETOPROTEINS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FEMALE; HUMANS; INFANT; MALE; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEOPLASMS, GERM CELL AND EMBRYONAL; PROGNOSIS; RISK FACTORS; SACROCOCCYGEAL REGION; TESTICULAR NEOPLASMS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 0037365850     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2003.03.125     Document Type: Article

References (30)

1. Berthold F, Trechow R, Utsch S, et al: Prognostic factors in metastatic neuroblastoma: A multivariate analysis of 182 cases. Am J Pediatr Hematol Oncol 14:207-215, 1992
2. Meyers A, Heller G, Healey JH, et al: Osteogenic sarcoma with clinically detectable metastases at initial presentation. J Clin Oncol 11:449-453, 1993
3. Beddis IR, Noblett H, Mott MG: Effective chemotherapy in metastatic malignant sacrococcygeal tumors. Med Pediatr Oncol 12:231-232, 1984
4. Baranzelli MC, Kramar A, Bouffet E, et al: Prognostic factors in children with localized malignant nonseminomatous germ cell tumors. J Clin Oncol 17:1212-1218, 1999
5. Göbel U, Calaminus G, Teske C, et al: BEP/VIP in children and adolescents with malignant non-testicular germ cell tumors: A comparison of the results of treatment of the therapy studies MAKEI 83/86 and 89/89P. Klin Pädiatr 205:231-240, 1993
6. Blohm MEG, Vesterling-Hörner D, Calaminus G, et al: Alpha1-Fetoprotein reference values in infants up to 2 years of age. Pediatr Hematol Oncol 15:135-142, 1998
7. 1-fetoprotein and human chorionic gonadotropic hormone in infancy and childhood. Pediatr Hematol Oncol 18:11-26, 2001
8. Calaminus G, Bamberg M, Baranzelli MC, et al: Intracranial germ cell tumors: A comprehensive update of the European data. Neuropediatrics 25:26-31, 1994
9. International Germ Cell Cancer Collaborative Group: International Germ Cell Tumor Consensus Classification: A prognostic factor based staging system for metastatic germ cell cancers. J Clin Oncol 15:594-603, 1997
10. Mostofi FK, Sobin LH: Histopathological Typing of Testis Tumours. Geneva, Switzerland, World Health Organization, 1993
11. Serov SF, Scully RE: Histopathological Typing of Ovarian Tumors. Geneva, Switzerland, World Health Organization, 1973
12. Gonzalez-Crussi F, Winkler RF, Mirkin DL: Sacrococcygeal teratonas in infants and children: Relationship of history and prognosis in 40 cases. Arch Path Lab Med 102:420-425, 1978
13. International Union Against Cancer: UICC TNM Atlas: Illustrated Guide to TNM/pTNM Classification of Malignant Tumours. New York, NY, Springer, 1992
14. Mulders PFA, Oosterhof GON, Boetes C, et al: The importance of prognostic factors in the individual treatment of patients with disseminated germ cell tumors. Br J Urol 66:425-429, 1990
15. Göbel U, Haas RJ, Calaminus G, et al: Treatment of germ cell tumors in children: Results of European trials for testicular and non-testicular primary sites. Crit Rev Oncol Hematol 10:89-98, 1990
16. Göbel U, Schneider DT, Calaminus G, et al: Multimodal treatment of malignant sacrococcygeal germ cell tumors: A prospective analysis of 66 patients of the German cooperative protocols MAKEI 83/86 and 89. J Clin Oncol 19:1943-1950, 2001
17. Brodeur GM, Howart CB, Pratt CB, et al: Malignant germ cell tumors in 57 children and adolescents. Cancer 48:1890-1898, 1981
18. Mann JR, Pearson D, Barrett A, et al: Results of the United Kingdom Children's Cancer Study Group's malignant germ cell tumor studies. Cancer 63:1657-1667, 1989
19. Pinkerton CR, Pritchard J, Spitz L: High complete response rate in children with advanced germ cell tumors using cisplatin-containing combination chemotherapy. J Clin Oncol 4:194-199, 1986
20. Göbel U, Calaminus G, Haas RJ, et al: Combined chemotherapy in malignant non-seminomatous germ cell tumors: Results of a cooperative study of the German Society of Pediatric Oncology (MAKEI 83). Cancer Chemother Pharmacol 24:S34-S39, 1989 (suppl)
21. Ablin AR, Krailo MD, Ramsay NK, et al: Result of treatment of malignant germ cell tumors in 93 children: A report of the Children's Cancer Study Group. J Clin Oncol 9:1782-1792, 1991
22. Haas RJ, Schmidt P, Göbel U, et al: Treatment of malignant testicular tumors in childhood: Results of the German National Study 1982-1992. Med Pediatr Oncol 23:400-404, 1994
23. Calaminus G, Vesterling-Hörner D, Bökkerink JPM, et al: The prognostic value of serum alpha1-protein in children and adolescents with malignant extracranial non-testicular germ cell tumors. Klin Padiatr 203:246-250, 1991
24. Mann JR, Raafat F, Robinson K, et al: UKCCSG's Germ cell tumor (GCT) studies: Improving outcome for children with malignant extracranial non-gonadal tumours-Carboplatin, etopside, bleomycin are effective and less toxic than previous regimens. Med Pediatr Oncol 30:217-227, 1998
25. Billmire D, Vinocur C, Rescorla F, et al: Malignant mediastinal germ cell tumors: An Intergroup Study. J Pediatr Surg 36:18-24, 2001
26. Mauz-Körholz C, Harms D, Calaminus G, et al: Primary chemotherapy and conservative surgery for vaginal yolk sac tumor: Maligne Keimzell-tumoren Study group. Lancet 355:625, 2000
27. Mann JR, Raafat F, Robinson K, et al: The United Kingdom Children's Cancer Group's Second Germ Cell Tumor Study: Carboplatin, etoposide, and bleomycin are effective treatment for children with malignant extracranial germ cell tumors with acceptable toxicity. J Clin Oncol 18:3809-3818, 2000
28. Bussey KJ, Lawce HJ, Olson SB, et al: Chromosome abnormalities of eighty-one pediatric germ cell tumors: Sex-, age-, site-, and histopathology-related differences-A Children's Cancer Group study. Genes Chromosomes Cancer 25:134-146, 1999
29. Schneider DT, Schuster AE, Fritsch MK, et al: Multipoint imprinting analysis indicates a common precursor cell for gonadal and non-gonadal pediatric germ cell tumors. Cancer Res 61:7268-7276, 2001
30. Schneider DT, Schuster AE, Fritsch MK, et al: Genetische Analyse der Keimzelltumoren im Kindesalter mit komparativer genomischer Hybridisierung. Klin Pädiatr 213:204-211, 2001